Publicaciones en colaboración con investigadores/as de Hospital Clinico Universitario de Valencia (10)

2023

  1. Anti-inflammatory and immunomodulating effects of rilpivirine: Relevance for the therapeutics of chronic liver disease

    Biomedicine and Pharmacotherapy, Vol. 167

2022

  1. Down-Regulation of the Longevity-Associated Protein SIRT1 in Peripheral Blood Mononuclear Cells of Treated HIV Patients

    Cells, Vol. 11, Núm. 3

2021

  1. NNRTI and Liver Damage: Evidence of Their Association and the Mechanisms Involved

    Cells, Vol. 10, Núm. 7

2020

  1. p53 and p53-related mediators PAI-1 and IGFBP-3 are downregulated in peripheral blood mononuclear cells of HIV-patients exposed to non-nucleoside reverse transcriptase inhibitors

    Antiviral Research, Vol. 178

2017

  1. Efavirenz: What is known about the cellular mechanisms responsible for its adverse effects

    European Journal of Pharmacology, Vol. 812, pp. 163-173

  2. Tenofovir-induced toxicity in renal proximal tubular epithelial cells: Involvement of mitochondria

    AIDS, Vol. 31, Núm. 12, pp. 1679-1684

2015

  1. Efavirenz and the CNS: What we already know and questions that need to be answered

    Journal of Antimicrobial Chemotherapy, Vol. 70, Núm. 10, pp. 2693-2708

2012

  1. Metabolomics of the effect of AMPK activation by AICAR on human umbilical vein endothelial cells

    International Journal of Molecular Medicine, Vol. 29, Núm. 1, pp. 88-94

2011

  1. Twenty years of HIV-1 non-nucleoside reverse transcriptase inhibitors: Time to reevaluate their toxicity

    Current Medicinal Chemistry, Vol. 18, Núm. 14, pp. 2186-2195

2010

  1. Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells

    Hepatology, Vol. 52, Núm. 1, pp. 115-125